Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monitoring the IMmUological TOXicity of Drugs

NCT03480529 is registered in ClinicalTrials.gov with Groupe Hospitalier Pitie-Salpetriere as lead sponsor.

NCT NCT03480529
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03480529 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monitoring the IMmUological TOXicity of Drugs
Lead sponsor
Groupe Hospitalier Pitie-Salpetriere
Phase
Observational
Overall status
Completed
Start date
March 1, 2018
Completion date
March 10, 2018
Enrollment
662 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, capillary leak syndrome, hepatitis, rheumatoid arthritis, systemic lupus erythematosus